, Tracking Stock Market Picks
Enter Symbol:
Amerisourcebergen Corporation (holding Co) (ABC) [hlAlert]

up 47.06 %

Amerisourcebergen Corporation (holding Co) (ABC) rated Overweight with price target $77 by Barclays

Posted on: Wednesday,  Mar 5, 2014  12:25 PM ET by Barclays

Barclays rated Overweight Amerisourcebergen Corporation (holding Co) (NYSE: ABC) on 03/05/2014, when the stock price was $68.78. Since
then, Amerisourcebergen Corporation (holding Co) has gained 47.06% as of 11/18/2015's recent price of $101.15.
If you would have followed this Barclays's recommendation on ABC, you would have gained 47.06% of your investment in 623 days.

AmerisourceBergen Corporation (AmerisourceBergen) is a pharmaceutical services company, with operations in the United States and Canada. Servicing both healthcare providers and pharmaceutical manufacturers in the pharmaceutical supply channel, the Company provides drug distribution and related services. It distributes an offering of brand name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical and dialysis clinics, physicians, long-term care and other alternate site pharmacies, and other customers. The Company operates in the pharmaceutical distribution segment. In October 2008, the Company completed the divestiture of its former workers? compensation business, PMSI. On May 29, 2009, the Company acquired Innomar Strategies Inc.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/8/2015 12:25 PM Buy
91.24 90.00
as of 10/17/2014
1 Week down  -1.37 %
1 Month down  -0.90 %
3 Months up  4.31 %
1 YTD up  10.26 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/5/2014 12:25 PM Buy
68.78 77.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy